Mesoblast (MESO) FCF Margin (2016 - 2023)
Mesoblast (MESO) posted FCF Margin of 889.06% for Q2 2023, down 6.08% sequentially from 838.06% in Q1 2023, and down 26934.0% YoY from N/an in Q2 2022.
Mesoblast (MESO) FCF Margin (2016 - 2023) Analysis & Trends
Mesoblast has reported FCF Margin for 8 years, with the latest figure at 889.06% in Q2 2023.
- Quarterly FCF Margin fell 26934.0% year-over-year to 889.06% in Q2 2023, while the trailing twelve-month figure through Jun 2023 was 779.22% (down 13451.0% YoY) and the FY2025 annual result came in at 294.69%, up 53095.0% from the prior year.
- FCF Margin eased to 889.06% in Q2 2023 per MESO's latest filing, from 838.06% in the prior quarter.
- Over five years, FCF Margin peaked at 51.97% in Q2 2020 and troughed at 2158.39% in Q3 2020.
- A 5-year average of 912.84% and a median of 834.58% in 2019 frame the typical range for FCF Margin.
- The sharpest annual moves came in 2020 and 2021: FCF Margin tumbled 132730 bps in 2020, then surged 140699 bps in 2021.
- Over 5 years, FCF Margin stood at 67.55% in 2019, then plunged by 1920 bps to 1364.57% in 2020, then soared by 62 bps to 515.24% in 2021, then tumbled by 50 bps to 771.04% in 2022, then fell by 15 bps to 889.06% in 2023.
- According to Business Quant data, FCF Margin over the past three periods registered 889.06%, 838.06%, and 771.04% for Q2 2023, Q1 2023, and Q4 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.68% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -77,594.17% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 70.82% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 22.62% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -22.35% |
| 10 | Mesoblast | 2.01 Bn | 1.87 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -889.06% |
| Mar 31, 2023 | -838.06% |
| Dec 31, 2022 | -771.04% |
| Sep 30, 2022 | -643.85% |
| Jun 30, 2022 | -619.71% |
| Mar 31, 2022 | -771.71% |
| Dec 31, 2021 | -515.24% |
| Sep 30, 2021 | -751.40% |
| Jun 30, 2021 | -947.90% |
| Mar 31, 2021 | -1,249.80% |
| Dec 31, 2020 | -1,364.57% |
| Sep 30, 2020 | -2,158.39% |
| Jun 30, 2020 | -51.97% |
| Mar 31, 2020 | -956.03% |
| Dec 31, 2019 | -67.55% |
| Sep 30, 2019 | -831.09% |
| Jun 30, 2019 | -970.31% |
| Mar 31, 2019 | -2,033.49% |
| Dec 31, 2018 | 166.72% |
| Sep 30, 2018 | -1,784.84% |